Amy Walsh

Senior Vice President, External Manufacturing · Regeneron Pharmaceuticals

Biopharmaceuticals

Amy Walsh is senior vice president of external manufacturing at Regeneron Pharmaceuticals. She joined in 2002 and leads the team responsible for manufacturing by partners and contract manufacturing organizations across the global clinical and commercial portfolio.

Last reviewed: Oct 21, 2026

Amy Walsh

Senior Vice President, External Manufacturing Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Amy Walsh is senior vice president of external manufacturing at Regeneron Pharmaceuticals. She joined in 2002 and leads the team responsible for manufacturing by partners and contract manufacturing organizations across the global clinical and commercial portfolio.

Career Highlights

  • Joined Regeneron in 2002.
  • Leads external manufacturing for global clinical and commercial programs.
  • Previously held Regeneron roles in CMC, quality assurance and logistics.

Professional Journey

Walsh worked in manufacturing compliance at Merck and manufacturing development at GlaxoSmithKline before joining Regeneron in 2002.

Within Regeneron, her responsibilities have included CMC regulatory sciences, CMC program management, quality assurance and logistics. Those assignments connect regulatory, quality and supply experience with her subsequent manufacturing leadership.

She now serves as senior vice president of External Manufacturing. Her multidisciplinary team is responsible for manufacturing performed by partners and contract manufacturing organizations for all clinical and commercial programs globally.

Education

Regeneron’s current corporate biography does not provide degree information for Walsh.